找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: RNA Interference and CRISPR Technologies; Technical Advances a Mouldy Sioud Book 2020 Springer Science+Business Media, LLC, part of Springe

[復(fù)制鏈接]
樓主: 轉(zhuǎn)變
61#
發(fā)表于 2025-4-1 02:12:49 | 只看該作者
62#
發(fā)表于 2025-4-1 07:34:39 | 只看該作者
Chemical Modifications in RNA Interference and CRISPR/Cas Genome Editing Reagents, as continual efforts are being made to optimize ON efficacy. Over the years, RNA interference (RNAi) has become one of the main tools used to inhibit RNA expression across a wide variety of species. Efforts have been made to improve the exogenous delivery of the double-stranded RNA components to th
63#
發(fā)表于 2025-4-1 12:00:29 | 只看該作者
Preparation, Determination of Activity, and Biodistribution of Cholesterol-Containing Nuclease-Resiw molecular weight drugs. Despite significant progress in this area, the potential for therapeutic use of RNAi in humans is limited due to the lack of efficient delivery systems. Bioconjugation is one of the most promising methods for delivering siRNA to cells and tissues, since conjugation of siRNA
64#
發(fā)表于 2025-4-1 16:09:40 | 只看該作者
Multifunctional Nanodelivery Platform for Maximizing Nucleic Acids Combination Therapy,rating with other therapeutics; however, transporting siRNA and other active ingredients to the same location at the same time is challenging. Here, we report a novel multifunctional nanodelivery platform by sequentially layering several functional ingredients, such as siRNAs, microRNAs, peptides, a
65#
發(fā)表于 2025-4-1 20:55:51 | 只看該作者
66#
發(fā)表于 2025-4-1 23:06:46 | 只看該作者
Delivery of Functional Small RNAs via Extracellular Vesicles In Vitro and In Vivo,EVs have recently gained significant interest as a promising material for delivery of therapeutics. Small RNAs, including small interfering RNA (siRNA) and microRNA (miRNA), provide a great therapeutic strategy for treating human diseases. However, it remains a challenge to deliver unconjugated smal
67#
發(fā)表于 2025-4-2 04:13:17 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 08:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
革吉县| 准格尔旗| 林芝县| 大宁县| 株洲县| 隆安县| 曲靖市| 称多县| 犍为县| 古交市| 象山县| 溧水县| 宁明县| 新邵县| 广元市| 桂林市| 玛多县| 清镇市| 明溪县| 临夏市| 香格里拉县| 上栗县| 略阳县| 凤凰县| 巴里| 榆林市| 克山县| 丘北县| 泰宁县| 湘阴县| 垫江县| 杭锦后旗| 隆回县| 溆浦县| 安化县| 大城县| 钦州市| 北京市| 宁阳县| 颍上县| 怀化市|